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There are accumulating evidence showing that mitochondrial dysfunction is 
strongly associated with impaired insulin release and its actions in peripheral tissues.  
Adipose tissue is one of the important peripheral tissues that regulate the whole-body 
glucose homeostasis.  Metabolic imbalance of energy productions and impaired 
oxidative phosphorylation in this tissue may lead to mitochondrial dysfunction.  The 
present study sought to investigate the metabolic profile of 3T3-L1 adipocytes in the 
event of mitochondrial dysfunction.  The induction of mitochondria dysfunction in 
adipocytes were performed by using treatment of oligomycin and antimycin A (AA).  
Cell viability, triglyceride accumulation, glucose utilization and adenosine 
triphosphate (ATP) production were analyzed following treatment with these 
inhibitors.  Liquid chromatography tandem mass spectrometry (LC-MS/MS) was 
used to identify the alteration of metabolic profiles associated with mitochondrial 
dysfunction in adipocytes.  The result showed that oligomycin and AA treatment 
dramatically decreased cell viability by inducing mitochondrial dysfunction at the 
dose of 8 μM and 0.0128 μM, respectively.  The treated cells were found to exhibit 
increased intracellular accumulation of lipid droplets.  Both inhibitors significantly 
reduced glucose utilization and concomitantly impaired ATP production in 
adipocytes.  Importantly, metabolic profile of adipocytes with mitochondrial 
dysfunction identified glycerol, arachidonic acid, glutamic acid, ceramide and 
glycerolphosphoethanolamine (GPE) as predictors for such metabolic perturbations.  
These findings underscore the potential role of intracellular metabolite in 
pathogenesis of insulin resistance, thereby suggesting that mitochondrial dysfunction 










Bukti-bukti kajian menunjukkan bahawa disfungsi mitokondria adalah sangat 
berkaitan dengan kerosakan pelepasan dan tindakan insulin pada tisu periferal. Tisu 
adipos adalah salah satu tisu periferal penting yang mengawal homeostasis glukosa 
seluruh badan. Ketidakseimbangan metabolik dari segi pengeluaran tenaga dan 
pemfosforilan oksidatif pada tisu sasaran ini boleh membawa kepada disfungsi 
mitokondria. Kajian ini bertujuan untuk mengenalpasti profil metabolik sel lemak 
3T3-L1 sekiranya berlaku kegagalan fungsi mitokondria seiring dengan perubahan 
yang berlaku di peringkat metabolik. Disfungsi mitokondria dalam adipocytes telah 
diaruh dengan menggunakan oligomisin dan antimisin A (AA). Kebolehidupan sel, 
pengumpulan trigliserid, penggunaan glukosa dan pengeluaran adenosina trifosfat 
(ATP) telah dianalisis dengan kehadiran kedua aruhan ini. Kromatografi cecair 
dengan spektrometri jisim penerbangan (LC-MS/MS) telah digunakan untuk 
mengenal pasti perubahan metabolik yang dikaitkan dengan disfungsi mitokondria 
dalam sel lemak. Keputusan menunjukkan bahawa rawatan oligomisin dan AA telah 
mengurangkan kebolehidupan sel yang mendorong kepada disfungsi mitokondria 
masing-masing pada dos 8 μM dan 0.0128 μM.  Sel sel yang dirawat didapati telah 
mempamerkan peningkatan pengumpulan titisan lipid dalam sel. Kedua-dua perencat 
telah mengurangkan penggunaan glukosa dan menjejaskan pengeluaran ATP dalam 
sel lemak. Perubahan metabolik sel akibat disfungsi mitokondria telah dikenal pasti 
seperti gliserol, asid arakidonik, asid glutamik, seramida dan 
gliserolfosfoetanolamina (GPE) sebagai ramalan terhadap gangguan metabolik. 
Penemuan ini menekankan peranan potensi metabolik intrasel dalam patogenesis 
rintangan insulin, dan menunjukkan bahawa disfungsi mitokondria boleh membantu 
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1.1 Background of study 
 
 
 The role of mitochondria in adipocyte metabolism, specifically on 
mitochondrial respiratory function has been emphasized in recent studies (Bakar et 
al., 2014).  Indeed, mitochondrial abnormalities was known to lead to several 
pathological conditions characterized by aberrant insulin signaling, abnormal glucose 
utilization, lipid metabolism disorder and excessive triglyceride (TG) accumulation 
in several cell types.  Interestingly, mitochondrial dysfunction in adipocyte was 
associated with type 2 diabetes mellitus (T2DM), resulting from elevated free fatty 
acid (FFA) levels and impaired oxidative phosphorylation (OXPHOS).capacity 
(Guilherme et al., 2008; Muoio and Neufer, 2012). 
 
 
 Diabetes is characterized by high blood sugar level due to systemic 
malfunction of glucose regulation.  There are 3 types of diabetes.  Type 1 diabetes is 
as a result of autoimmune destruction of the insulin-producing beta cells in the 
pancreas.  A sufferer with this type of diabetes requires exogenous insulin for 
survival in order to avoid ketoacidonesis.  Type 2 diabetes is characterized by insulin 
resistance and has been linked with metabolic syndrome and a doubled risk for 
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cardiovascular disease.  Meanwhile, gestational diabetes may occur during 
pregnancy.  Among of these types, type 2 diabetes is the most prevalence form of 
diabetes characterized by decreased insulin sensitivity in various target tissues.  
International Diabetes Federation (IDF) estimated 366 million people worldwide 
suffered from this disease in 2011, and projected to rise to 552 million in 2030 
(Whiting et al., 2011).  A large proportion of these individuals remain undiagnosed 
due to lack of symptoms early on the disease.  Until now, there is no definitive 
clinical intervention to reverse diabetes and the understanding of its disease 
mechanism is still an open discussion. 
 
 
 Several studies have postulated that prominent feature of type 2 diabetes are 
regarded as mitochondrial dysfunction (Lowell and Shulman., 2005; Martin et al., 
2014).  Disruptions of mitochondrial function are known to cause an insulin-deficient 
form of diabetes.  Liu et al. (2012) demonstrated that reduction of adipogenic 
markers, typically prohibitins (PHBs) as a result of impairment of mitochondrial 
activity.  The impairment of PHB cause reduction of mitochondrial content, 
impairment of mitochondria complex 1 activity and excessive production of reactive 
oxygen species (ROS) that may lead to metabolic disorder.  
 
 
 Recently, the use of the 3T3-L1 adipocytes as differentiation model to study 
their role in metabolic syndrome were increasing.  The adipocyte is a lipid depository 
sites and a key metabolic regulator responsible for the production of cytokines, 
metabolic substrate and adipokines which influence the whole body metabolic 
activity (Roberts et al , 2009) .  Therefore, numerous basic and clinical researches 
have been devoted toward the dysregulation of metabolism within adipose tissue that 
may contribute to the progressions of T2DM, metabolic syndrome and obesity. 
 
 
 Even though there are several in vitro studies performed using 3T3-L1 
adipocyte in analyzing the mechanistic of insulin resistance, glucose uptake and lipid 
metabolism cell culture models that highlighted the metabolite profile in adipocyte 
dysfunction of T2DM is still lacking.  Determination of metabolite concentrations 
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and detections provide complementary information to the mechanistic understanding 
of a particular diseases.  The methods based on Mass Spectrometry (MS) remain 
dominant analytical platforms.  Mass spectrometry-based metabolomics provide a 
quantitative analysis with high selectivity and sensitivity.  These approaches also 
have potential to identify metabolite of interest and its aetiological pathways for 





1.2 Problem Statement 
 
 
 Over a past few years, adipose tissue has been acknowledge to exert the 
whole blood glucose homeostasis and modulate various metabolic functions in both 
normal and diseases states such as insulin resistance, T2DM, hypertension, 
dyslipidemia and even some cancers (De Pauw et al., 2009; Sam and Mazzone, 
2014).  Recently, type 2 diabetes contributes to major epidemic cases in developing 
nations especially among young people (Shaw et al., 2010; Weill et al, 2012). 
 
 
 Adipocyte cell store and release triglycerides (TGs) as well as regulate 
several metabolic functions in endocrine activity since adipocyte secretes a specific 
hormone and proinflammotary cytokines, namely, adipokines or adipocytokines 
which provide an extensive network of communication within adipose tissue and 
other organ.  Importantly, this network of communication regulate energy 
homeostasis in organism (Ahima, 2006).  However, the interaction adipose tissue 
depots are distinguished between white adipose tissue (WAT) and brown adipose 
tissue (BAT).  Although BAT originates from the myogenic lineage, it shares many 
features of WAT (Seale et al., 2008).  WAT has been recognized as main storage of 
excess energy from food intake as metabolic active, lipid storage and endocrine 
organ.  A better understanding mechanism involved in adipocyte differentiation is 
required to reveal mechanism underlying diabetes and insulin resistance.  This 
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understanding is important to develop new therapeutic approach that directly target 
intracellular pathway in adipocytes. 
 
 
 Although adipocyte dysfunction linking obesity to insulin resistance have 
been recently reviewed (Guilherme et al., 2008), the role of mitochondrial 
dysfunction associated with T2DM in and mature adipocyte differentiation had 
hardly been addressed.  Moreover, the metabolic activities are different between 
subcutaneous and visceral WAT, depending on their anatomical position and 
mitochondrial content (Wajchenberg, 2000).  Deveaud et al. (2004) reported that, in 
the visceral depot, adipocytes are richer in mitochondrial compared to subcutaneous 
adipocytes.  Mitochondrial is known to play an essential role in physiological and 
metabolic activity in the pathology of human disease including type 2 diabetes.  
 
 
Although there is clear association between insulin resistance, type 2 diabetes 
(T2DM) and mitochondrial dysfunction, there is no compelling evidence of 
metabolite isolation as potential marker in the development of diabetes.  Thus, the 
aim of this study has been directed towards elucidation of the cellular metabolite 
profile of mitochondrial dysfunction induced diabetic cell cultured that involved in 
the development insulin resistance and type 2 diabetes. 
 
 
 In the study of mitochondria dysfunction in the adipose tissue, we hope to 
elucidate the impact of mitochondrial activity in adipocyte biology.  These ideas may 
lead to the novel understanding of the effects of mitochondrial stress on adipocytes 
and their systemic metabolic functions as well the potential metabolite profile as a 








1.3  Research Hypothesis 
 
 
 Metabolite profiling of mitochondria dysfunction activity detectable in 





1.4 Objective of the Research 
 
 
 In this research, the metabolite profiling of mitochondria dysfunction in 3T3-
L1 adipocyte cell was investigated.  Drug-induced mitochondrial activity in 3T3-L1 
adipcoytes utilizing various concentrations may affect the mitochondrial biogenesis 
and the non-targeted approach of metabolomics were studied.  The objective of this 
research was: 
To establish the metabolomics marker in oligomycin and Antimycin A (AA)-





1.5 Scope of the Research 
 
 
 In order to achieve the objectives of the research, the experimental work was 
divided into three major scopes.  The scopes of the research were:  
i) Preparation of dysfunctional mitochondria 3T3-L1 adipocytes model using 
oligomycin and Antimycin A.  
 
ii) Analysis of the treated cells of oligomycin and antimycin A by determining 
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